Alaunos Therapeutics, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
With Mr. Huang’s departure, the Board has elected Holger Weis as the Company’s new Chairman of the Board.
On September 22, 2023, James Huang resigned as Chairman and member of the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) with immediate effect in order to focus on other business pursuits.
Extracted from this filing and checked against the source text.
Holger Weis was elected as Chairman at Alaunos Therapeutics, Inc..
With Mr. Huang’s departure, the Board has elected Holger Weis as the Company’s new Chairman of the Board.View on SEC.gov
James Huang resigned as Chairman at Alaunos Therapeutics, Inc..
On September 22, 2023, James Huang resigned as Chairman and member of the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) with immediate effect in order to focus on other business pursuits.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.